Bristol Myers Squibb is paying $600 million up front to begin a 13-drug collaboration with Hengrui Pharma spanning oncology, hematology, and immunology. That tops a 12-drug pact GSK inked last year with Hengrui, a China-based company that has global growth ambitions.
The post Bristol Myers, Hengrui Pharma Team Up in Global Drug Research Pact That Could Top $15B appeared first on MedCity News.
What is weaponised JPEG file? Here's how hackers use fake images to deploy malware – Geo News
What is weaponised JPEG file? Here’s how hackers use fake images to deploy malware Geo News
